- call +1-201-465-4211
- email sales@mrinsights.biz
Albumin is a water soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
Scope of the Report:
This report focuses on the Albumin (as Excipient) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increase in usage of albumin as multifunctional excipient, shift toward usage of recombinant albumin, and grant of regulatory approvals are the key factors driving the market. However, high cost and expertise required to set up production plants and stringent regulatory criteria restrain the market. Emerging markets such as India, China, Brazil, and South Africa present significant opportunities in the albumin as an excipient market owing to growing contract research manufacturing.
The worldwide market for Albumin (as Excipient) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Albumedix A/S (Novozyme A/S)
Albumin Therapeutics
Biotest
CSL Behring
Grifols International
HiMedia Laboratories
InVitria
Medxbio
Octapharma
RayBiotech
SeraCare Life Sciences
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Human Serum Albumin
Recombinant Albumin
Market Segment by Applications, can be divided into
Pharmaceutical & Biotechnology Industry
Research Institutes
Others
There are 15 Chapters to deeply display the global Albumin (as Excipient) market.
Chapter 1, to describe Albumin (as Excipient) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Albumin (as Excipient), with sales, revenue, and price of Albumin (as Excipient), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Albumin (as Excipient), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Albumin (as Excipient) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Albumin (as Excipient) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Albumin (as Excipient) Introduction
1.2 Market Analysis by Type
1.2.1 Human Serum Albumin
1.2.2 Recombinant Albumin
1.3 Market Analysis by Applications
1.3.1 Pharmaceutical & Biotechnology Industry
1.3.2 Research Institutes
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Albumedix A/S (Novozyme A/S)
2.1.1 Business Overview
2.1.2 Albumin (as Excipient) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Albumedix A/S (Novozyme A/S) Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Albumin Therapeutics
2.2.1 Business Overview
2.2.2 Albumin (as Excipient) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Albumin Therapeutics Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biotest
2.3.1 Business Overview
2.3.2 Albumin (as Excipient) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biotest Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 CSL Behring
2.4.1 Business Overview
2.4.2 Albumin (as Excipient) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CSL Behring Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Grifols International
2.5.1 Business Overview
2.5.2 Albumin (as Excipient) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Grifols International Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 HiMedia Laboratories
2.6.1 Business Overview
2.6.2 Albumin (as Excipient) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 HiMedia Laboratories Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 InVitria
2.7.1 Business Overview
2.7.2 Albumin (as Excipient) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 InVitria Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Medxbio
2.8.1 Business Overview
2.8.2 Albumin (as Excipient) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medxbio Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Octapharma
2.9.1 Business Overview
2.9.2 Albumin (as Excipient) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Octapharma Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 RayBiotech
2.10.1 Business Overview
2.10.2 Albumin (as Excipient) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 RayBiotech Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 SeraCare Life Sciences
2.11.1 Business Overview
2.11.2 Albumin (as Excipient) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 SeraCare Life Sciences Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck
2.12.1 Business Overview
2.12.2 Albumin (as Excipient) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck Albumin (as Excipient) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Albumin (as Excipient) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Albumin (as Excipient) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Albumin (as Excipient) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Albumin (as Excipient) Manufacturer Market Share in 2017
3.3.2 Top 6 Albumin (as Excipient) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Albumin (as Excipient) Market Analysis by Regions
4.1 Global Albumin (as Excipient) Sales, Revenue and Market Share by Regions
4.1.1 Global Albumin (as Excipient) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Albumin (as Excipient) Revenue and Market Share by Regions (2013-2018)
4.2 North America Albumin (as Excipient) Sales and Growth Rate (2013-2018)
4.3 Europe Albumin (as Excipient) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Albumin (as Excipient) Sales and Growth Rate (2013-2018)
4.5 South America Albumin (as Excipient) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Albumin (as Excipient) Sales and Growth Rate (2013-2018)
5 North America Albumin (as Excipient) by Countries
5.1 North America Albumin (as Excipient) Sales, Revenue and Market Share by Countries
5.1.1 North America Albumin (as Excipient) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Albumin (as Excipient) Revenue and Market Share by Countries (2013-2018)
5.2 United States Albumin (as Excipient) Sales and Growth Rate (2013-2018)
5.3 Canada Albumin (as Excipient) Sales and Growth Rate (2013-2018)
5.4 Mexico Albumin (as Excipient) Sales and Growth Rate (2013-2018)
6 Europe Albumin (as Excipient) by Countries
6.1 Europe Albumin (as Excipient) Sales, Revenue and Market Share by Countries
6.1.1 Europe Albumin (as Excipient) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Albumin (as Excipient) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Albumin (as Excipient) Sales and Growth Rate (2013-2018)
6.3 UK Albumin (as Excipient) Sales and Growth Rate (2013-2018)
6.4 France Albumin (as Excipient) Sales and Growth Rate (2013-2018)
6.5 Russia Albumin (as Excipient) Sales and Growth Rate (2013-2018)
6.6 Italy Albumin (as Excipient) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Albumin (as Excipient) by Countries
7.1 Asia-Pacific Albumin (as Excipient) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Albumin (as Excipient) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Albumin (as Excipient) Revenue and Market Share by Countries (2013-2018)
7.2 China Albumin (as Excipient) Sales and Growth Rate (2013-2018)
7.3 Japan Albumin (as Excipient) Sales and Growth Rate (2013-2018)
7.4 Korea Albumin (as Excipient) Sales and Growth Rate (2013-2018)
7.5 India Albumin (as Excipient) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Albumin (as Excipient) Sales and Growth Rate (2013-2018)
8 South America Albumin (as Excipient) by Countries
8.1 South America Albumin (as Excipient) Sales, Revenue and Market Share by Countries
8.1.1 South America Albumin (as Excipient) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Albumin (as Excipient) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Albumin (as Excipient) Sales and Growth Rate (2013-2018)
8.3 Argentina Albumin (as Excipient) Sales and Growth Rate (2013-2018)
8.4 Colombia Albumin (as Excipient) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Albumin (as Excipient) by Countries
9.1 Middle East and Africa Albumin (as Excipient) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Albumin (as Excipient) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Albumin (as Excipient) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Albumin (as Excipient) Sales and Growth Rate (2013-2018)
9.3 UAE Albumin (as Excipient) Sales and Growth Rate (2013-2018)
9.4 Egypt Albumin (as Excipient) Sales and Growth Rate (2013-2018)
9.5 Nigeria Albumin (as Excipient) Sales and Growth Rate (2013-2018)
9.6 South Africa Albumin (as Excipient) Sales and Growth Rate (2013-2018)
10 Global Albumin (as Excipient) Market Segment by Type
10.1 Global Albumin (as Excipient) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Albumin (as Excipient) Sales and Market Share by Type (2013-2018)
10.1.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2013-2018)
10.2 Human Serum Albumin Sales Growth and Price
10.2.1 Global Human Serum Albumin Sales Growth (2013-2018)
10.2.2 Global Human Serum Albumin Price (2013-2018)
10.3 Recombinant Albumin Sales Growth and Price
10.3.1 Global Recombinant Albumin Sales Growth (2013-2018)
10.3.2 Global Recombinant Albumin Price (2013-2018)
11 Global Albumin (as Excipient) Market Segment by Application
11.1 Global Albumin (as Excipient) Sales Market Share by Application (2013-2018)
11.2 Pharmaceutical & Biotechnology Industry Sales Growth (2013-2018)
11.3 Research Institutes Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Albumin (as Excipient) Market Forecast (2018-2023)
12.1 Global Albumin (as Excipient) Sales, Revenue and Growth Rate (2018-2023)
12.2 Albumin (as Excipient) Market Forecast by Regions (2018-2023)
12.2.1 North America Albumin (as Excipient) Market Forecast (2018-2023)
12.2.2 Europe Albumin (as Excipient) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Albumin (as Excipient) Market Forecast (2018-2023)
12.2.4 South America Albumin (as Excipient) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Albumin (as Excipient) Market Forecast (2018-2023)
12.3 Albumin (as Excipient) Market Forecast by Type (2018-2023)
12.3.1 Global Albumin (as Excipient) Sales Forecast by Type (2018-2023)
12.3.2 Global Albumin (as Excipient) Market Share Forecast by Type (2018-2023)
12.4 Albumin (as Excipient) Market Forecast by Application (2018-2023)
12.4.1 Global Albumin (as Excipient) Sales Forecast by Application (2018-2023)
12.4.2 Global Albumin (as Excipient) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Albumin (as Excipient) Picture
Table Product Specifications of Albumin (as Excipient)
Figure Global Sales Market Share of Albumin (as Excipient) by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
